MedPath

Study The effect of DARVYADIGHANVATI IN exessive per vaginal bleeding during menstrual cycle in PUBERTY .

Phase 3
Conditions
Health Condition 1: E308- Other disorders of puberty
Registration Number
CTRI/2020/07/026517
Lead Sponsor
DrKavita chandrashekhar mule
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age 13 yrs to 19 years

Patients with prolonged cycles,

excessive bleeding p/v during menstruation, more than three pads

Dysfunctional Uterine Bleeding

Hb% 8 grams% and above

Exclusion Criteria

H/o Endocrinal disorders

H/o Bleeding dyscrasias

Intermenstrual bleeding

H/o Structural abnormality in genital organs

H/o Any other systemic illness

H/o Genital tuberculosis

PCOD

Hb% < 8gm%

H/o Juvenile Diabetes Mellitus

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
minimize exessive bloodloss in Asrugdhara (Puberty menorragia)Timepoint: 15 weeks
Secondary Outcome Measures
NameTimeMethod
TO Minimize Excessive Blood Loss . An Alternative Hormonal Therapy In Puberty MenorrhagiaTimepoint: whiten three month of period
© Copyright 2025. All Rights Reserved by MedPath